Keep Me Logged In
Joseph Hedden, analyst at Datamonitor Healthcare, says that the clinical and commercial potential of immunotherapies against cancer is growing but that there appears to be no front-runner.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by